TrialBMC gastroenterology2022

Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study.

Ping'an Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.